Please assess the completion status of the following clinical trial:

Trial Title: Study of the Inflammation and Airway Changes That Occur After Exposure to Allergen in Asthmatics

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Allergic/Non-Asthmatic subjects and Allergic/Asthmatic subjects~Inclusion Criteria:~* Positive skin test to dust mite or cat allergen~Non-Allergic/Non-Asthmatic subjects~Inclusion Criteria:~* Negative skin test to panel of 12 allergens, including dust mite and cat allergen~All groups~Exclusion Criteria:~* History of intubation for asthma exacerbation~* Use of Xolair (omalizumab) within the last 6 months~* Immunotherapy with cat or dust mite extract now or in the past 5 years~* ≥ 10 pack-years smoking or any smoking in the past year~* Other lung diseases, such as sarcoidosis, bronchiectasis or active lung infection~* History of dermatographia~* History of anaphylaxis to cat allergen~* Participation in another research study involving a drug or biologic during the past 30 days~* Presence of past or current medical problems/other factors that may pose additional risks from participation or influence study results, as determined per study investigator

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 50 Years
- Healthy Volunteers: t

Study Arms:
- Allergen challenge subjects (Type: EXPERIMENTAL): Intervention: Segmental airway allergen challenge~Three types of subjects are studied in this arm:~1) Volunteers with neither asthma nor allergy (as established by skin prick testing); 2) Volunteers with allergy (as established by skin prick testing) but without asthma; and 3) Volunteers with both asthma and allergy (as established by skin prick testing)

Based on this trial design, predict the completion outcome and termination type (if applicable).